|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/51 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 3860998 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19791146.4 |
| Date of filing the European patent application | 2019-10-04 | |
| (97) | Date of publication of the European application | 2021-08-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation | 2024-06-25 |
| (86) | Number | PCT/US2019/054880 |
| Date | 2019-10-04 |
| (87) | Number | WO 2020/073011 |
| Date | 2020-04-09 |
| (30) | Number | Date | Country code |
| 201862742218 P | 2018-10-05 | US |
| (72) |
TANG, Haifeng , US
HANSON, Michael , US
BOYCE, Sarah , US
NIE, Zhe , US
|
| (73) |
Annapurna Bio Inc. ,
2145 Clement Street, San Francisco CA 94121,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su APJ receptoriaus aktyvumu |
| COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2025-08-28 | 7 | 162.00 EUR |
| 2026-10-04 |